Navigation Links
ApoCell's Cancer Predictive Index Helps Oncologists Select the Most,Effective Targeted Drug Therapy

HOUSTON--(BUSINESS WIRE)--Jun 7, 2007 - ApoCell, Inc. presented the results of a study conducted by researchers at the University of Chicago and ApoCell at the 2007 annual meeting of the American Society of Clinical Oncology (ASCO) held in Chicago in early June. The study showed that ApoCell's advanced pharmacodynamic biomarker assay technology provides reliable predictive data of clinical response. This study showed the benefit of treating aggressive head and neck cancer patients with a combination of targeted molecular drugs.

Cancer treatment is evolving from the use of highly toxic systemic compounds to targeted molecular drugs that are safer and faster acting because they aim only at cancer cell structures and their bio-mechanisms. Pharmacodynamics is an evolving field that encompasses the study of the biochemical and physiological effects of drugs, the mechanisms of drug action and the relationship between drug concentration and biological effect.

ApoCell has developed an analytical tool, the PDx Index(TM) (Pharmaco-Diagnostic Index), which indicates the likelihood of whether a targeted therapy will elicit a clinical response. The predictive index in this study was derived by comparing the biochemical state of a cancer cell receptor that is critical to the process of angiogenesis or vascularization of tumors. This PDx Index(TM) of patients with head and neck cancer showed a direct correlation between the drug regimen and patient response. This new technology is applicable to predicting the clinical outcome of most molecular targeted cancer drugs.

Dr. Darren Davis, ApoCell's President and CEO comments, "We have developed the PDx Index(TM) methodology to give drug developers, clinical investigators and oncologists a quantitative tool to predict effectiveness of cancer drug treatment. Recent research has demonstrated that different individuals respond differently to the same cancer drug therapy.
'"/>




Page: 1 2

Related medicine technology :

1. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Protox Announces Positive Clinical Data from Prostate Cancer Study
6. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
7. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
8. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
9. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
10. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
11. Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression
Post Your Comments:
(Date:5/4/2015)... 4, 2015 Bayer HealthCare (Bayer) has entered ... (NASDAQ: ISIS ) on ISIS-FXI Rx, an ... of thrombosis. Under the agreement Bayer will further develop ... unmet medical need. As part of the clinical development ... ISIS-FXI Rx in an appropriate patient community. ...
(Date:5/4/2015)... FRAMINGHAM, Mass. , May 4, 2015   HeartWare ... of less invasive, miniaturized circulatory support technologies that are revolutionizing ... and CEO, Doug Godshall , is scheduled to present ... Conference in Las Vegas on Thursday, ... The live webcast of the Company,s presentation at ...
(Date:5/4/2015)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) has entered ... to develop and commercialize ISIS-FXI Rx for the ... Isis is eligible to receive up to $155 million ... payment and a $55 million payment upon advancement of ... with compromised kidney function. Isis is also eligible to ...
Breaking Medicine Technology:Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5
... honor of National Women,s Health Week, Someone With ... home health and medical supply online storefront, www.someonewith.com , ... catalog solutions for more than 2.5 million breast cancer survivors ... women who will be diagnosed with breast cancer this year. ...
... (NYSE Amex: ANX ) today reported financial results ... "We are pleased to have completed the acquisition of SynthRx ... to reach agreement on the protocol for a pivotal phase ... crisis," said Brian M. Culley, Chief Executive Officer of ADVENTRX. ...
Cached Medicine Technology:Someone With Opens its Doors to Create Online Marketplace for Breast Cancer Products and Services 2Someone With Opens its Doors to Create Online Marketplace for Breast Cancer Products and Services 3Someone With Opens its Doors to Create Online Marketplace for Breast Cancer Products and Services 4ADVENTRX Reports First Quarter 2011 Financial Results 2ADVENTRX Reports First Quarter 2011 Financial Results 3ADVENTRX Reports First Quarter 2011 Financial Results 4ADVENTRX Reports First Quarter 2011 Financial Results 5
(Date:5/5/2015)... (PRWEB) May 05, 2015 ... H2 2014” provides comparative analysis on the ... strengthens R&D pipelines by identifying new targets ... products. Complete report is available at ... this Liver Fibrosis – Pipeline Review, H2 ...
(Date:5/5/2015)... Woodbridge, NJ (PRWEB) May 05, 2015 Texting ... it is no surprise that some physicians text as a ... always, we urge providers who are doing so to assure ... Texting does not come without risk! When providers transmit ... their mobile devices, they run the risk of violating the ...
(Date:5/5/2015)... No one cares about health problems until ... and Prevention cite multiple sources causing poor indoor air ... air quality (pollution) can bother your eyes, nose, and throat. ... and cancer.” , Toxic chemicals often get into the human ... water, or in some cases, absorb them through our skin. ...
(Date:5/4/2015)... Garden City, NY (PRWEB) May 05, 2015 ... honors Patti Hommes as a 2015-2016 ... She is recognized with this prestigious distinction for leadership ... exclusively for professional women, boasting more than 700,000 members ... to recognize Patti with this important honor,” says NAPW ...
(Date:5/4/2015)... Every Friday afternoon at A Forever Recovery, a ... patients and staff gather in the common room to ... and to gain encouragement and inspiration in their continuing ... one, those patients who have completed their recovery programs ... to share a bit about their journey with the ...
Breaking Medicine News(10 mins):Health News:Liver Fibrosis Therapeutic Development and Pipeline Market Review H2 2014 Available at RnRMarketResearch.com 2Health News:Liver Fibrosis Therapeutic Development and Pipeline Market Review H2 2014 Available at RnRMarketResearch.com 3Health News:HIPAA Compliant Texting Service from MedXcom now available for Policyholders 2Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 2Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 3Health News:NAPW Inducts Patti Hommes, Director of Advancement Services, Springside Chestnut Hill Academy, a 2015-2016 Professional Woman of the Year Circle 2Health News:A Forever Recovery Celebrates New Victories in Overcoming Addiction With Weekly Graduation 2
... News) -- The worldwide diabetes epidemic continues to worsen, ... disease, 4.6 million deaths due to it each year, ... International Diabetes Federation announced Tuesday. The federation ... Association for the Study of Diabetes in Lisbon, Portugal, ...
... case-control and cohort studies on the association of alcohol consumption ... from Asia, 2 from Australia, 13 from Western Europe, and ... alcohol, at least at higher levels of consumption, is associated ... Overall, there was no increase in the risk for consumers ...
... to be presented at the upcoming HFES 55th Annual ... describe WISE, a Web-based tool for breast cancer survivors ... Those who have beaten breast cancer comprise the ... Many return to the workplace after treatment, but symptoms ...
... HealthDay Reporter , TUESDAY, Sept. 13 (HealthDay News) -- ... developing high blood pressure than whites are, but new research ... state to full-blown high blood pressure. The ... Hypertension , suggest that intervening earlier with medication, as ...
... against cervical cancer. This is the conclusion of the broadest ... group in Viruses and Cancer of IDIBELL, published at ... who uses IUD halved the risk of developing cervical cancer ... are contrary to popular belief that IUD could be a ...
... Alan Mozes HealthDay Reporter , MONDAY, Sept. 12 ... by the U.S. Food and Drug Administration are foolproof and ... But when informed of safety concerns about a drug, ... important gaps in what people know about approved drugs, and ...
Cached Medicine News:Health News:366 Million People Now Have Diabetes: Report 2Health News:Relation of alcohol consumption to colorectal cancer 2Health News:Web tool aims to improve the workplace for breast cancer survivors 2Health News:Blacks Develop High Blood Pressure a Year Ahead of Whites 2Health News:IUD reduces the risk of cervical cancer 2Health News:Public Often Unaware of a Drug's Safety Record -- Or Lack of One 2Health News:Public Often Unaware of a Drug's Safety Record -- Or Lack of One 3Health News:Public Often Unaware of a Drug's Safety Record -- Or Lack of One 4
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
Medicine Products: